FALLOPIAN TUBE ADENOCARCINOMA
Clinical trials for FALLOPIAN TUBE ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new FALLOPIAN TUBE ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for FALLOPIAN TUBE ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can heated chemotherapy improve ovarian cancer outcomes?
Disease control CompletedThis trial is testing a procedure called HIPEC, where a heated chemotherapy drug (cisplatin) is delivered directly into the abdomen after surgery to remove visible cancer. The goal is to find the safest dose that can be used in patients with advanced ovarian, fallopian tube, or p…
Matched conditions: FALLOPIAN TUBE ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Immunotherapy combo shows promise in ovarian cancer trial
Disease control CompletedThis study tested two immunotherapy drugs, durvalumab and tremelimumab, given with chemotherapy before and after surgery for advanced ovarian cancer. The goal was to see if this combination is safe and feasible. About 69 women with stage IIIC to IV ovarian cancer took part. The r…
Matched conditions: FALLOPIAN TUBE ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: ARCAGY/ GINECO GROUP • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC